PTPS-15ATRX LOSS PROMOTES TUMOR GROWTH AND IMPAIRS NON-HOMOLOGOUS END JOINING DNA REPAIR IN GLIOMA

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuro-oncology

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/NEUONC/NOV228.15
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of ATRX Suppresses Resolution of Telomere Cohesion to Control Recombination in ALT Cancer Cells.

  2015cited by this paper
• Mutational landscape and clonal architecture in grade II and III gliomas

  2015cited by this paper
• Transposon mediated integration of plasmid DNA into the subventricular zone of neonatal mice to generate novel models of glioblastoma.

  2015cited by this paper
• Alpha Thalassemia/Mental Retardation Syndrome X-linked Gene Product ATRX Is Required for Proper Replication Restart and Cellular Resistance to Replication Stress*

  2013cited by this paper
• DNA Damage in Mammalian Neural Stem Cells Leads to Astrocytic Differentiation Mediated by BMP2 Signaling through JAK-STAT

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Insights gained from modelling high‐grade glioma in the mouse

  2012cited by this paper
• Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

  2012cited by this paper
• The DNA damage response and cancer therapy

  2012cited by this paper
• Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway

  2012cited by this paper
• Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

  2012cited by this paper
• MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.

  2011cited by this paper
• Microsatellite Instability in Pediatric High Grade Glioma Is Associated with Genomic Profile and Differential Target Gene Inactivation

  2011cited by this paper
• Microsatellite instability in radiation-induced murine tumours; influence of tumour type and radiation quality

  2010cited by this paper
• A genome-wide RNA interference screen reveals an essential CREB3L2/ATF5/MCL1 survival pathway in malignant glioma with therapeutic implications

  2010cited by this paper
• Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.

  2010cited by this paper
• De novo induction of genetically engineered brain tumors in mice using plasmid DNA.

  2009cited by this paper
• Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model.

  2009cited by this paper
• DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.

  2009cited by this paper
• Cells of adult brain germinal zone have properties akin to hair cells and can be used to replace inner ear sensory cells after damage

  2008cited by this paper
• Real-time PCR assay for measurement of mouse telomeres.

  2006cited by this paper
• Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response

  2006cited by this paper
• DNA damage-induced cell death by apoptosis.

  2006cited by this paper
• Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors

  2005cited by this paper
• Role of DNA-PK in the cellular response to DNA double-strand breaks.

  2004cited by this paper
• Molecular-clinical spectrum of the ATR-X syndrome.

  2000cited by this paper
• The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations.

  2000cited by this paper
• Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo.

  1999cited by this paper

• No citing papers are available for this paper.